LifeFlow Sepsis Study

Prospective Trial Of Patient Outcomes and PALS Sepsis Guideline Adherence In Patients Fluid Resuscitated With The LifeFlow® Rapid Infuser Compared To Traditional Methods

This is a prospective, comparative, blinded, randomized study to prove the safety, efficacy and ease of use of the LifeFlow® device in pediatric patients presenting to an emergency department with concern for sepsis. This study will include 600 patients, 300 will receive the LifeFlow® device to deliver intravenous fluids while another 300 patients will receive the conventional push/pull method.

Inclusion Criteria:

• Less than 19 years old
• Trigger the Best Practice Alert in triage
• Treating physician elects to do the full sepsis bundle.

Exclusion Criteria:

• Less than 20kg in weight
• Patients on diuretics for cardiac or renal conditions
• Patients who cannot communicate in either English or Spanish